Dimethyl fumarate: targeting glycolysis to treat MS

被引：20
|
作者：
Angiari, Stefano [1 ]
O'Neill, Luke A. [1 ]
机构：
[1] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland
来源：
CELL RESEARCH | 2018年 / 28卷 / 06期
基金：
英国惠康基金;
关键词：
D O I：
10.1038/s41422-018-0045-3
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Dimethyl fumarate (DMF) is an immunomodulatory drug used in patients with multiple sclerosis (MS) and psoriasis. Kornberg and colleagues shed new light on DMF activity, demonstrating that it blocks immune cell activation through inhibition of glycolysis via post-transcriptional modification of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which confirms the pro-inflammatory role of glycolysis and points to potential new targets to treat inflammatory diseases such as MS.
引用
收藏
页码：613 / 615
页数：3
相关论文
共 50 条
  • [41] UPDATED ANALYSIS OF PREGNANCY OUTCOMES FOR PATIENTS WITH MS IN A DIMETHYL FUMARATE EXPOSURE REGISTRY
    Rog, David
    Hellwig, Kerstin
    McGuigan, Christopher
    Mokliatchouk, Oksana
    Branco, Filipe
    Lyons, Jennifer
    Everage, Nicholas
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [42] Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate
    Alshehri, A.
    Al-Iedani, O.
    Koussis, N.
    Khormi, I.
    Lea, R.
    Lechner-Scott, J.
    Ramadan, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 376 - 376
  • [43] Effectiveness of initial MS treatments in the COMBAT-MS trial: injectables, dimethyl fumarate, natalizumab and rituximab
    Alping, P.
    Burman, J.
    Fink, K.
    Fogdell-Hahn, A.
    Gunnarsson, M.
    Hillert, J.
    Langer-Gould, A.
    Lycke, J.
    Nilsson, P.
    Olsson, T.
    Salzer, J.
    Svenningsson, A.
    Vrethem, M.
    Frisell, T.
    Piehl, F.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 21 - 22
  • [44] Systematic Evaluation of Dimethyl Fumarate induced Lymphopenia in Multiple Sclerosis (MS) Patients
    Malik, Muhammad Taimur
    Zhang, Yanfei
    Lee, Ming
    NEUROLOGY, 2021, 96 (15)
  • [45] Correction to: Dimethyl fumarate
    Reactions Weekly, 2018, 1721 (1) : 93 - 93
  • [46] Synthesis of dimethyl fumarate
    Wang, Cunde
    Niu, Xiuqin
    Zhang, Jungui
    Xu, Jian
    Huagong Xiandai/Modern Chemical Industry, 1998, 18 (06): : 28 - 29
  • [47] Interference Of GI Symptoms With Daily Activities And Work Productivity In MS Patients Treated With Diroximel Fumarate Versus Dimethyl Fumarate
    Naismith, R. T.
    Wolinsky, J. S.
    Jasinska, E.
    Chen, H.
    Leigh-Pemberton, R.
    Hanna, J.
    Messer, J.
    Miller, C.
    Wundes, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 138 - 139
  • [48] Disrupting metabolism to treat autoimmunity Dimethyl fumarate, a treatment for multiple sclerosis, inhibits Warburg metabolism
    Matsushita, Mai
    Pearce, Edward J.
    SCIENCE, 2018, 360 (6387) : 377 - 378
  • [49] JC Titers in Multiple Sclerosis (MS) Patients Treated With Rituximab, Fingolimod and Dimethyl Fumarate at an American MS center
    Gottesman, Malcolm H.
    Farley, Stephen
    Friedman-Urevich, Sharon
    Ye, Janin
    Grueneberg, Denise
    Martone, Lorraine
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 96 - 97
  • [50] Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS
    Talbot, J.
    Chow, H. Hojsgaard
    Hansen, R. Holm
    von Essen, M. Rode
    Sellebjerg, F.
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 361
12345